发现A20与4-(2-甲基) -1-H-pyrazole支架作为一种强效和选择性的ROCK2抑制剂
相关实验视频
Updated: Sep 9, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.8K
Junzheng Wang1, Bin Peng1, Guodong Liang1
1Key Laboratory for Candidate Medicine Design and Screening Based on Chemical Biology, College of Pharmacy, Inner Mongolia Medical University, Hohhot, PR China.
Bioorganic & medicinal chemistry letters
|August 31, 2025
概括
研究人员优化了一种向Rho相关蛋白激酶2 (ROCK2) 的化合物,这是神经疾病和纤维化的关键蛋白质. 新的化合物A20显示强大的ROCK2抑制, 提供潜在的治疗效益.
科学领域:
- 生物化学
- 医学化学
- 药理学
背景情况:
- 关联蛋白激酶2 (ROCK2) 是神经疾病和纤维性疾病的重要治疗点.
- 开发强效和选择性的ROCK2抑制剂对于疾病治疗至关重要.
研究的目的:
- 根据其与ROCK2的结合模式,对化合物M214进行结构优化.
- 确定具有增强ROCK2抑制活性的新化合物.
主要方法:
- 基于结构的药物设计和优化.
- 在体外的酶抑制试验以确定ROCK2和ROCK1的IC50值.
- 分子对接模拟以阐明结合相互作用.
主要成果:
- 化合物A20具有4- ((2-甲基) - 1H- 皮拉基架,对ROCK2具有优异的抑制活性 (IC50=0. 18μM).
- A20还抑制了ROCK1的IC50为3. 0μM,这表明了一些选择性.
- 分子对接显示了A20和ROCK2残留物 (Met172,Glu170) 之间的关键键相互作用.
结论:
- 化合物A20是作为ROCK2抑制剂进一步开发的有希望的候选物.
- 已确定的结构特征和结合相互作用为设计更强效和选择性的ROCK抑制剂提供了基础.
- 用A20等优化化合物向ROCK2具有治疗神经和纤维状况的潜力.
相关概念视频
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K

